Assessment of the risk of falls in patients with Parkinson’s disease using Time Up and Go
Objective: This study aimed to evaluate the risk of falls in patients participating in the group of physical activities for Parkinson's of UNICAMP using the…Post-stroke movement disorders: an analysis of 24 cases
Objective: To define prevalence of post-stroke movement disorders and correlate their clinical presentation with infarct localisation. Background: Stroke related movement disorders are rare, they can…Neuropathological findings in a SPG4 gene mutation carrier
Objective: To describe the clinical and neuropathological findings of a patient carrier of a mutation in the SPG4 gene. Background: Hereditary spastic paraplegia (HSP) linked…Creutzfeld Jacob disease presenting with functional-appearing, bizarre movements without significant cognitive impairment
Objective: To report unusual presentation of Creutzfeld Jacob disease (CJD) with bizarre movements and functional characteristics. Background: Prion disease is most commonly due to CJD…MicroRNA Expression in the Diagnosis of Parkinson’s Disease
Objective: To identify plasma-derived microRNAs (miRNAs) to serve as potential diagnostic and prognostic biomarkers of Parkinson’s disease (PD). Background: PD is characterized by the progressive…Enhancing the Proteasomal Degradation of Alpha Synuclein: “The Hallmark” to attenuating the Progression of Parkinson’s Disease
Objective: The research aimed at preventing the accumulation of Alpha Synuclein in order to prevent it's accumulation. It is imperative that we also establish that…Multiple System Atrophy – perspectives in diagnosis?
Objective: The aim of this study was to study the role of perfusion single photon emission computed tomography (SPECT) in the examination of multiple system…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Therapeutic management of complicated Parkinson’s disease: clinical application of the Motor Fluctuation Indices
Objective: To evaluate the usefulness of the Motor Fluctuation Indices to assess clinically relevant change in motor fluctuations in advanced Parkinson’s disease (PD) patients after…Contribution of pedunculopontine nucleus cholinergic neurons to L-DOPA-induced dyskinesia and PD motor deficits in hemi-parkinsonian rats
Objective: To determine if chemogenetic and pharmacological modulation of pedunculopontine nucleus (PPN) cholinergic neurons can alter L-DOPA-induced dyskinesia and gait deficits in hemi-parkinsonian rats. Background:…
- « Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 217
- Next Page »